sr 46349b has been researched along with pimavanserin in 1 studies
Studies (sr 46349b) | Trials (sr 46349b) | Recent Studies (post-2010) (sr 46349b) | Studies (pimavanserin) | Trials (pimavanserin) | Recent Studies (post-2010) (pimavanserin) |
---|---|---|---|---|---|
51 | 1 | 7 | 159 | 23 | 134 |
Protein | Taxonomy | sr 46349b (IC50) | pimavanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0335 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0464 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0464 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnt, J; Ebdrup, BH; Glenthøj, B; Rasmussen, H | 1 |
1 review(s) available for sr 46349b and pimavanserin
Article | Year |
---|---|
Serotonin 2A receptor antagonists for treatment of schizophrenia.
Topics: Antipsychotic Agents; Brain; Fluorobenzenes; Humans; Phenols; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Urea | 2011 |